ENG/中
老虎证券
行情
交易
收费
下载
优惠与活动
帮助
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
股权激励
关于
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Bioptix, Inc.
7.67
0.0000
成交量:
- -
成交额:
- -
市值:
4,144.87万
市盈率:
-6.24
高:
7.67
开:
7.67
低:
7.67
收:
7.67
52周最高:
11.17
52周最低:
2.32
股本:
540.40万
流通股本:
450.40万
量比:
- -
换手率:
- -
股息:
- -
股息率:
- -
每股收益(TTM):
-1.2300
净资产收益率:
--
总资产收益率:
--
市净率:
3.76
市盈率(LYR):
- -
数据加载中...
总览
公司
新闻资讯
公告
公司资料
公司名字:
Bioptix, Inc.
交易所:
NASDAQ
成立时间:
- -
员工人数:
- -
公司地址:
- -
官网:
http://www.bioptix.com/
邮编:
- -
电话:
- -
传真:
- -
简介:
Bioptix, Inc.致力于推进解决未满足的人类诊断需求的产品。 Bioptix,Inc.于2000年7月24日作为科罗拉多州公司组织生产用于诊断应用的纯化蛋白质。 到目前为止,该公司已利用公司的科学技术推进公司APPY1产品候选人的开发,并开发了动物健康相关资产,包括知识产权。 2012年,公司对这些动物健康相关资产进行了授权,如下所述。 公司的研究和开发活动目前主要集中在人类急性阑尾炎基于血液的测试。
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠:港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投,免费实时行情与多种工具,立即开户享更多优惠!","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠:港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投,免费实时行情与多种工具,立即开户享更多优惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BIOP/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BIOP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOP\",,,,,undefined,":{"symbol":"BIOP","market":"US","secType":"STK","nameCN":"Bioptix, Inc.","latestPrice":7.67,"timestamp":1508356800000,"preClose":7.67,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":4503971,"shares":5404000,"eps":-1.23,"marketStatus":"退市","change":0,"latestTime":"10-18 16:00:00 EDT","open":7.67,"high":7.67,"low":7.67,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.23,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":7.67,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOP\",,,,,undefined,":{"symbol":"BIOP","floatShares":4503971,"roa":"--","roe":"--","lyrEps":0,"shares":5404000,"dividePrice":0,"high":7.67,"amplitude":0,"preClose":7.67,"low":7.67,"week52Low":2.32,"pbRate":"3.76","week52High":11.17,"institutionHeld":0,"latestPrice":7.67,"eps":-1.23,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.23,"open":7.67},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIOP\",params:#limit:5,,,undefined,":[{"date":"2017-10-19","symbol":"BIOP","newSymbol":"RIOT","type":"symbolChange","dateTimestamp":1508385600000},{"market":"US","date":"2017-10-12","symbol":"BIOP","amount":1,"name":"Bioptix, Inc.","currency":"USD","type":"dividend","dateTimestamp":1507780800000},{"market":"US","date":"2017-08-11","symbol":"BIOP","fiscalQuarterEnding":"2017/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1502424000000,"reportTimeType":"","actualEps":-0.21},{"market":"US","date":"2017-05-15","symbol":"BIOP","fiscalQuarterEnding":"2017/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1494820800000,"reportTimeType":"","actualEps":-0.22},{"market":"US","date":"2016-11-14","symbol":"BIOP","fiscalQuarterEnding":"2016/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1479099600000,"reportTimeType":"","actualEps":-0.43}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIOP\",market:\"US\",,,undefined,":[{"executeDate":"2017-10-12","recordDate":null,"paymentDate":null,"value":1,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIOP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.bioptix.com/","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Bioptix, Inc.致力于推进解决未满足的人类诊断需求的产品。 Bioptix,Inc.于2000年7月24日作为科罗拉多州公司组织生产用于诊断应用的纯化蛋白质。 到目前为止,该公司已利用公司的科学技术推进公司APPY1产品候选人的开发,并开发了动物健康相关资产,包括知识产权。 2012年,公司对这些动物健康相关资产进行了授权,如下所述。 公司的研究和开发活动目前主要集中在人类急性阑尾炎基于血液的测试。","exchange":"NASDAQ","name":"Bioptix, Inc.","nameEN":"Bioptix, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"BIOP\",market:\"US\",,,undefined,":null}}